Head and neck neuroendocrine tumors at a single institution over 15 years

Maria Bacalao; Muhammad S Beg; Dominick Cavuoti; Hong Zhu; Baran Sumer; Larry Myers; John Truelson; Lucien Nedzi; David Sher; Randall Hughes; Saad A Khan

doi:10.1002/ccr3.2545

Head and neck neuroendocrine tumors at a single institution over 15 years

Clin Case Rep. 2019 Nov 17;7(12):2508-2512. doi: 10.1002/ccr3.2545. eCollection 2019 Dec.

Authors

Maria Bacalao¹, Muhammad S Beg², Dominick Cavuoti³, Hong Zhu⁴, Baran Sumer⁵, Larry Myers⁵, John Truelson⁵, Lucien Nedzi⁶, David Sher⁶, Randall Hughes², Saad A Khan²

Affiliations

¹ Department of Medicine UT Southwestern Medical Center Dallas Texas.
² Division of Hematology and Oncology/Harold C. Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas Texas.
³ Department of Pathology UT Southwestern Medical Center Dallas Texas.
⁴ Department of Clinical Sciences UT Southwestern Medical Center Dallas Texas.
⁵ Department of Otolaryngology UT Southwestern Medical Center Dallas Texas.
⁶ Department of Radiation Oncology UT Southwestern Medical Center Dallas Texas.

Abstract

Head and neck cancer is a diverse group of rare diseases such as neuroendocrine tumors which can be thought of as extrapulmonary small-cell cancer. Surgery, chemotherapy, and radiation can frequently cure this disease, possibly due to early detection.

Keywords: head and neck cancer; larynx cancer; neuroendocrine cancer.

Publication types

Case Reports